Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

https://www.thelancet.com/journals/eclinm/issue/vol71nonull/PIIS2589-5370(24)X0005-X